Aurotussin Peak Cold Maximum Strength Multi-symptom Cold while Breastfeeding

What is Aurotussin Peak Cold Maximum Strength Multi-symptom Cold used for?

Is Aurotussin Peak Cold Maximum Strength Multi-symptom Cold safe to use while breastfeeding? Can it interfere with growth and development of my kid?

Dextromethorphan hydrobromide while Breastfeeding

CAS Number: 125-71-3

Cough suppressant related with morphine and codeine which is lacking of analgesic or sedative properties. Commonly prescribed by pediatricians. On latest update relevant data on breastfeeding was not found. Because reported low toxicity and mild side effect it is considered to be safe while breastfeeding. Frequently associated to caffeine and other products that are usually compatible with breastfeeding. Avoid use of multiple drug and alcohol containing medication.

Guaifenesin while Breastfeeding

CAS Number: 93-14-1

It is used as an expectorant, alone or in association with other products. Proofs on its effectiveness are sparse. In some instances, preparations of Guaifenesin may contain alcohol as excipient with a concentration as high as 5%. At latest update, relevant published data on excretion into breast milk were not found. Until more information on this medication is available, other option known to be safer would be recommended, mostly in the post-natal period or in cases of prematurity. If used while breastfeeding, a moderate use with the lowest dose as possible and avoiding those preparations with alcoholic excipient, should be preferred. Because effectiveness is poor and likelihood of side effects does exist, especially in multi-association, the US Agency for Drug Administration (FDA) is currently doing efforts for discontinuation of this and others at-the-counter products, that are formulated for cough relief (Guaifenesin, Dextromethorphan, Phenylephrine, Pseudoephedrine, Brompheniramine, etc.)

Phenylephrine hydrochloride while Breastfeeding

CAS Number: 59-42-7

Used on topical decongestant solutions for nose drops at low concentration. 10% midriatic eye drops are available. Because low concentration is used on nose and ophtalmic drops a significant excretion into breast milk is unlikely. Low oral biodisponibility minimizes any risk of harmful effect in the infant. Authorized for nasal or ophtalmic use on children aged younger than 1 year. Although on latest update relevant data on breastfeeding was not found it is considered to be safe when minimal dose is used. Avoid excessive or long term use. A related drug Pseudoephedrine can inhibit milk production. It would be advisable to press on the lachrimal sac to minimize absorption.

Dextromethorphan hydrobromide while Breastfeeding

CAS Number: 125-71-3

Neither the excretion of dextromethorphan in milk nor its effect on breastfed infants have been studied. It is unlikely that with usual maternal doses amounts in breastmilk would harm the nursing infant, especially in infants over 2 months of age. It is best to avoid the use of products with a high alcohol content while nursing.

Guaifenesin while Breastfeeding

CAS Number: 93-14-1

Neither the excretion of guaifenesin in milk nor its effect on breastfed infants have been studied. It is unlikely that with usual maternal doses amounts in breastmilk would harm the nursing infant, especially in infants over 2 months of age. It is best to avoid the use of products with a high alcohol content while nursing.

Phenylephrine hydrochloride while Breastfeeding

CAS Number: 59-42-7

The oral bioavailability of phenylephrine is only about 40%,[1] so the drug is unlikely to reach the infant in large amounts. However, intravenous or oral administration of phenylephrine might decrease milk production. Because no information is available on the use of oral phenylephrine during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.Phenylephrine nasal spray or ophthalmic drops are less likely to decrease lactation. To substantially diminish the effect of the drug after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.

What should I do if I am breastfeeding mother and I am already exposed to Aurotussin Peak Cold Maximum Strength Multi-symptom Cold?

My health care provider has asked me to use Aurotussin Peak Cold Maximum Strength Multi-symptom Cold, what to do?

If I am using Aurotussin Peak Cold Maximum Strength Multi-symptom Cold, will my baby need extra monitoring?

Who can I talk to if I have questions about usage of Aurotussin Peak Cold Maximum Strength Multi-symptom Cold in breastfeeding?